Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Bristol Myers Squibb is shedding two clinical programs, one from its 2023 Mirati buyout and another from a partnership with U ...

Advanced simulations have been the subject of fiction from The Matrix to the season two episode of The Twilight Zone (2019), ...

It may sound counterintuitive to use AI to prepare for AI, but this recursive strategy is what enables scalable ... like a ...

The support network that has emerged through the Mises Institute is really important. We feel like we’re all alone, but ...

By Yuen Yuen Ang Conflicts, trade wars, inequality, and democratic decay fill today’s headlines. Each crisis appears to be ...

Microsoft Azure has been experiencing a global outage since around 1600 UTC, or 0900 PDT on Wednesday, October 29, 2025. As Azure staggers back to its feet following an hours-long outage last night, ...

If you're an artist doing retro-style work (or you dream of getting started) and you'd like to do more with your Linux ...

Prompt injection attacks are a security flaw that exploits a loophole in AI models, and they assist hackers in taking over ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, Kimberly-Clark’s $40 billion Kenvue deal, and more.